Answer
In a population study of intravenous topotecan hydrochloride, co-administered ondansetron did not appear to significantly affect the pharmacokinetics of total topotecan, including its active and inactive forms.
Sources for this answer
- Topotecan Hospira 4 mg/4 ml concentrate for solution for infusionPfizer Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 18Document updated
Sources checked